Chen et al. illustrate that cancer cell derived dysfunctional COL1A1 homotrimers can lead remodeling of the tumor microbiome, diminishing T-cell infiltration, and reducing anti-PD-1 immunotherapeutic response [43]. This evidence concerns the gene COL1A1 and cancer.